Biofrontera AG Sponsored ADR Operating Income Growth

Operating Income Growth of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Income Growth for the quarter ending March 31, 2022 was 117.86% (a 230.33% increase compared to previous quarter)
  • Year-over-year quarterly Operating Income Growth increased by 6752.33%
  • Annual Operating Income Growth for 2021 was -380.9% (a -670.29% decrease from previous year)
  • Annual Operating Income Growth for 2020 was 66.79% (a -434.28% decrease from previous year)
  • Annual Operating Income Growth for 2019 was -19.98% (a -48.18% decrease from previous year)
  • Twelve month Operating Income Growth ending March 31, 2022 was 41.5% (a 1995.96% increase compared to previous quarter)
  • Twelve month trailing Operating Income Growth decreased by -133.98% year-over-year
Trailing Operating Income Growth for the last four month:
31 Mar '22 30 Sep '21 31 Mar '21 30 Sep '20
41.5% 1.98% -48.16% -122.12%
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income Growth of Biofrontera AG Sponsored ADR

Most recent Operating Income Growthof BFAGY including historical data for past 10 years.

Interactive Chart of Operating Income Growth of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Operating Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 117.86%
2021 35.68% -56.67% -380.9%
2020 1.72% -17.96% 66.79%
2019 -162.25% -189.69% -19.98%
2018 -1.75% -38.56%
2017 15.23% 61.87% -20.83%
2016 211.49% 17.24%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic